Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLondon Capital Group Holdings Regulatory News (LCG)

  • There is currently no data for LCG

Financing Update

1 Oct 2014 16:11

RNS Number : 2126T
London Capital Group Holdings PLC
01 October 2014
 



London Capital Group Holdings plc

("LCG" or the "Company")

Financing update

 

Further to the Company's announcement on 17 June 2014, concerning the proposed financing to raise up to £17,500,000, through the Issue of convertible loan notes to GLIO and Institutional Investors, LCG is pleased to announce that it has entered into a convertible loan note instrument ("Institutional Investors CLN Instrument") relating to the subscription of £2,000,000 in principal amount of unsecured convertible loan notes of £1.00 each in the capital of the Company (the "CLN Subscription") by the following persons ("Institutional Investors") and in the following proportions:-

a) Hargreave Hale (registered in the name of HSBC Global Custody Nominee (UK) Limited) for £1,000,000 convertible loan notes; and

b) Mr Tyler Rameson (registered in the name of JIM Nominees Limited) for £1,000,000 convertible loan notes,

(together, the "CLNs") each at a conversion price to be determined, according to the conversion price calculation, referred to in the Institutional Investors CLN Instrument. In connection with and conditional on the above CLN Subscription, the Company shall issue warrants to the Institutional Investors, to subscribe for new ordinary shares of £0.10 each in the capital of the Company in proportion to the number of CLNs to be subscribed for by the Institutional Investors, each at a price of 45 pence per share.

Following the recent relevant Approvals of Mr Charles-Henri Sabet and GLIO, as announced by the Company on 14 August 2014, the Institutional Investors CLNs will become due for subscription once the conversion price has been determined (assuming that there is no outstanding event of default and LCG's net assets are not less than £8.5 million) in accordance with the terms referred to in the Institutional Investors CLN Instrument. A further announcement(s) will be made in due course following the subscription of the convertible loan notes by GLIO and the Institutional Investors respectively.

Save where the context requires, capitalised terms within this announcement have the same meaning as those in the Circular to Shareholders, published on 17 June 2014.

 

For further information, please contact: www.londoncapitalgroup.com

 

London Capital Group Holdings plc 

Charles-Henri Sabet, Executive Chairman

020 7456 7000

 

Cenkos Securities plc

Nicholas Wells

020 7397 8900

 

Smithfield Consultants

John Kiely

020 7360 4900

 

Notes to Editors:

London Capital Group Holdings plc (hereafter "LCGH plc" or "LCG" or "London Capital Group" or "the Group") is a financial services company offering online trading services.

London Capital Group Limited (LCG Ltd), a wholly owned trading subsidiary of LCGH plc, is authorised and regulated by the Financial Conduct Authority. Its core activity is the provision of spread betting and CFD products on the financial markets to retail clients under the trading names Capital Spreads, Capital CFDs and LCG MT. Its other division provides online foreign exchange trading services to institutional and professional clients. LCG Ltd is one of the leading providers of white label financial spread trading and CFD platforms and its white label partners include TD Direct Investing, Bwin.party, and Saxo Bank.

 LCG Ltd has a European passport and is a member of the London Stock Exchange. LCG Ltd also has access to international markets through its global clearing relationships.

 LCGH plc is listed on the London Stock Exchange's AIM market. LCG is included in the General Financial sector (8770) and Speciality Finance sub sector (8775) and has a RIC code of LCG.L.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUBDGGBGBGSB
Date   Source Headline
3rd Feb 20108:49 amRNSHolding(s) in Company
28th Jan 20107:00 amRNSContinuation of E*TRADE white label
15th Jan 20107:00 amRNSWhite Label Agreement
12th Jan 20107:00 amRNSTrading Statement
8th Dec 20094:40 pmRNSSecond Price Monitoring Extn
8th Dec 20094:35 pmRNSPrice Monitoring Extension
7th Dec 200912:28 pmRNSTrading Statement
2nd Dec 20098:41 amRNSHolding(s) in Company
24th Aug 200912:50 pmRNSDirector/PDMR Shareholding
18th Aug 20097:00 amRNSHalf Yearly Report
8th Jul 200911:18 amRNSTrading Statement
19th Jun 20096:11 pmRNSAnnual Financial Report
19th Jun 20094:40 pmRNSSecond Price Monitoring Extn
19th Jun 20094:35 pmRNSPrice Monitoring Extension
2nd Jun 20099:37 amRNSHistoric accounting adjustment
28th Apr 200912:51 pmRNSHolding(s) in Company
27th Apr 200910:22 amRNSDirector/PDMR Shareholding
24th Apr 200910:12 amRNSIssue of Equity
22nd Apr 20091:31 pmRNSAGM Statement
15th Apr 200912:00 pmRNSIssue of Equity
9th Apr 200912:00 pmRNSBoard Reorganisation
8th Apr 20093:16 pmRNSIssue of Equity
6th Apr 20094:10 pmRNSIssue of Equity
27th Mar 20095:47 pmRNSDirector/PDMR Shareholding
19th Mar 20099:07 amRNSIssue of Equity
18th Feb 20097:00 amRNSFinal Results
2nd Feb 20097:00 amRNSSaxo Bank White Label Agreement
6th Jan 20097:00 amRNSTrading Statement
22nd Dec 20083:57 pmRNSIssue of Equity
24th Nov 20084:54 pmRNSSecond Price Monitoring Extn
24th Nov 20084:40 pmRNSPrice Monitoring Extension
13th Oct 20084:02 pmRNSHolding(s) in Company
9th Oct 20081:18 pmRNSDirector/PDMR Shareholding
6th Oct 20089:19 amRNSHolding(s) in Company
7th Aug 20087:00 amRNSInterim Results
4th Jul 20089:13 amRNSHolding(s) in Company
2nd Jul 20087:00 amRNSTrading Statement
30th Jun 200812:37 pmRNSIssue of Equity
17th Jun 200810:00 amRNSDirector/PDMR Shareholding
13th Jun 20083:30 pmRNSIssue of Equity
27th May 20087:00 amRNSAcquisition of FuturesBetting
23rd Apr 200811:44 amRNSAGM Statement
7th Apr 200810:04 amRNSHolding(s) in Company
3rd Apr 20083:02 pmRNSDirector/PDMR Shareholding
1st Apr 200811:04 amRNSAnnual Report and Accounts
20th Feb 20087:00 amRNSFinal Results
28th Jan 20087:00 amRNSNotice of Results
3rd Jan 200812:16 pmRNSTrading Statement
26th Nov 20077:01 amRNSDirector/PDMR Shareholding
20th Nov 20076:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.